Study: Cholesterol was lowered with an oral PCSK9 inhibitor.

Published Date: 08 Mar 2023

A new study conducted by Baylor College of Medicine and presented at the American College of Cardiology Annual Scientific Session as well as the World Congress of Cardiology shows that an oral PCSK9 inhibitor called MK-0616...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

For the first time in humans, a chemotherapy drug reaches the brain.

2.

BMI is linked to heart damage from chemotherapy in breast cancer patients.

3.

Clinical trial results show low-intensity therapy can achieve positive outcomes for certain pediatric leukemia subtypes

4.

Immunotherapy after surgery is good for patients with advanced cancer

5.

Biomarker-Selected Treatment Shows Promise for Bladder Preservation in MIBC


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot